Dissolution Testing in Pharma - From Development to Regulatory Approval
Watch the Course Now
Watch the Course Now
About the Course
Dissolution testing plays a central role in demonstrating pharmaceutical product performance, supporting bioavailability assessment, formulation development, and ongoing quality control. Weak or inconsistent dissolution practices can create significant compliance and manufacturing concerns, including batch failures, regulatory observations, and product recalls. Regulatory expectations from FDA, USP, and ICH place increased emphasis on scientifically justified methods, reliable apparatus qualification, and consistent execution throughout the product life cycle.
The course addresses the scientific and operational factors that influence dissolution behavior, including particle size, solubility, pKa, diffusion models, excipient selection, and manufacturing conditions. Attention is also given to apparatus selection, calibration practices, discriminating method development, IVIVC evaluation, validation activities, and troubleshooting approaches linked to FDA 483 findings. These areas directly affect data reliability, submission quality, and confidence in batch-to-batch consistency during development and commercial production. The material supports phase-appropriate decision making across formulation, analytical, quality, and regulatory functions.
Key Areas Covered
Quality training, expert insights, and answers that matter. Know your Expert
Ready to Strengthen Your Team? Let’s Build Your Training Plan.
Your team deserves the clarity.
Your organization deserves the confidence.
Upcoming Courses
Your TalkFDA Webinar Experience
1. Confirmation
3. Access course materials
4. Watch The Streaming and Complete your Course


